|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0017817,
umls-concept:C0030705,
umls-concept:C0054252,
umls-concept:C0178539,
umls-concept:C0205179,
umls-concept:C0370003,
umls-concept:C0456205,
umls-concept:C1140680,
umls-concept:C1280500,
umls-concept:C1441547,
umls-concept:C1533691,
umls-concept:C1550605,
umls-concept:C1709059,
umls-concept:C2347026
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2002-4-25
|
|
pubmed:abstractText |
The objective was to assess the relationship between glutathione content and drug sensitivity with glutathione modulation in ovarian cancer in a pilot study using 31 samples of freshly obtained ovarian tumor material from 26 patients with advanced disease.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0090-8258
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
(c) 2002 Elsevier Science (USA).
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
85
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
298-304
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11972391-Antimetabolites, Antineoplastic,
pubmed-meshheading:11972391-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:11972391-Buthionine Sulfoximine,
pubmed-meshheading:11972391-Cisplatin,
pubmed-meshheading:11972391-Doxorubicin,
pubmed-meshheading:11972391-Drug Resistance, Multiple,
pubmed-meshheading:11972391-Drug Resistance, Neoplasm,
pubmed-meshheading:11972391-Drug Screening Assays, Antitumor,
pubmed-meshheading:11972391-Drug Synergism,
pubmed-meshheading:11972391-Female,
pubmed-meshheading:11972391-Glutathione,
pubmed-meshheading:11972391-Humans,
pubmed-meshheading:11972391-Multidrug Resistance-Associated Proteins,
pubmed-meshheading:11972391-Ovarian Neoplasms,
pubmed-meshheading:11972391-Pilot Projects,
pubmed-meshheading:11972391-Prognosis,
pubmed-meshheading:11972391-Tumor Cells, Cultured
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
Cellular glutathione content, in vitro chemoresponse, and the effect of BSO modulation in samples derived from patients with advanced ovarian cancer.
|
|
pubmed:affiliation |
Haematology Research, Pembury Hospital, Pembury, Tunbridge Wells, Kent TN2 4QJ, United Kingdom.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
